Kips Bay Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

KIPS 0.0120 -0.0010 (-7.69%)
price chart
Kips Bay Medical, Inc. (OTCMKTS:KIPS) Looks to Dissolution as eMESH-I Fails ...
Kips Bay Medical, Inc. (OTCMKTS:KIPS) is suffering from a setback in its phase-1 clinical feasibility trials for eMESH I. As per the announcement, the early angiographic results reflected poorly on the implants and the company would be winding down ...
Manny Villafa�a's Kips Bay Medical shutting down
Kips Bay Medical Inc. will wind down operations after receiving disappointing results from a clinical trial. The Plymouth-based med-tech company makes a mesh device used during coronary artery bypass grafting surgery.
Kips Bay Medical, Inc. (OTCMKTS:KIPS) Annunces First Quarter 2015 Results
Kips Bay Medical, Inc. (OTCMKTS:KIPS) net sales in 1Q2015 came at $8000 compared to $26,000 in 1Q2014. The decline indicates the effects of reorganization plans implemented in January 2015 as it reduced its two sales directors and shifted focus on ...
Kips Bay Medical, Inc. (OTCMKTS:KIPS) Gets Slaughtered
Kips Bay Medical, Inc. (OTCMKTS:KIPS, KIPS message board) is not a new company. It has been around for a while and it has a product.
Kips Bay Medical Announces an Orderly Wind Down of Operations With the ...
MINNEAPOLIS, June 29, 2015 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (OTCQB:KIPS) today announced its decision to terminate its eMESH I clinical feasibility trial due to poor early angiographic results from enrolled patients who had an eSVS Mesh ...
Kips Bay Medical Announces $3.25 Million Private Placement Bridge Financing
MINNEAPOLIS, March 24, 2015 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS� Mesh, for use in coronary ...
Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 ...
MINNEAPOLIS, May 12, 2015 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS� Mesh, for use in coronary artery ...
Villafa�a's Kips Bay Medical raises $16.5 million in IPO
Medical device start-up Kips Bay Medical Inc. raised $16.5 million Friday in the year's first initial public offering for a Minnesota company.
Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results
MINNEAPOLIS, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company that was focused on manufacturing and commercializing its external saphenous vein support technology, eSVS� Mesh, for use in ...
Kips Bay Medical Announces FDA Approval for U.S. Expansion of Its eMESH I ...
MINNEAPOLIS, March 17, 2014 (GLOBE NEWSWIRE) -- Kips Bay Medical, Inc. (Nasdaq:KIPS) along with Manny Villafa�a, its Founder, Chairman and CEO, announced today that the United States Food & Drug Administration ("FDA") has granted an approval ...
Related articles »